Literature DB >> 4987170

Immunoglobulin synthesis and total body tumor cell number in IgG multiple myeloma.

S E Salmon, B A Smith.   

Abstract

Studies of synthesis of IgG paraproteins were performed in 10 patients who had IgG myeloma in order to quantitate cellular immunosynthetic functions and derive estimates of the number of tumor cells present in such patients. Serial in vitro studies demonstrated constancy in the cellular rate of IgG paraprotein secretion for up to 8 months. Average molecular synthesis rates in different patients ranged from 12,500 to 85,000 molecules of IgG per minute per myeloma cell. Estimated total body tumor cell number ranged from 0.5 x 10(12) to 3.1 x 10(12) myeloma cells, and could be correlated with the degree of skeletal damage observed on roentgenograms (P = <0.01). Serial measurements of tumor cell number may prove useful in characterizing the growth rate and natural history of multiple myeloma. Myeloma is the first metastatic human malignancy in which quantitative measurements of the body's burden of malignant cells have been obtained.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4987170      PMCID: PMC322579          DOI: 10.1172/JCI106327

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  21 in total

Review 1.  PLASMA CELL MYELOMA: GAMMA GLOBULIN SYNTHESIS AND STRUCTURE. A REVIEW OF BIOCHEMICAL AND CLINICAL DATA, WITH THE DESCRIPTION OF A NEWLY-RECOGNIZED AND RELATED SYNDROME, "H-GAMMA-2-CHAIN (FRANKLIN'S) DISEASE.

Authors:  E F OSSERMAN; K TAKATSUKI
Journal:  Medicine (Baltimore)       Date:  1963-11       Impact factor: 1.889

2.  THE METABOLISM OF GAMMA GLOBULINS IN MYELOMA AND ALLIED CONDITIONS.

Authors:  C A ALPER; T FREEMAN; J WALDENSTROEM
Journal:  J Clin Invest       Date:  1963-12       Impact factor: 14.808

3.  MYELOMA PROTEINS AND THE CLINICAL RESPONSE TO MELPHALAN THERAPY.

Authors:  D E DE BERGSAGEL; P J MIGLIORE; K M GRIFFITH
Journal:  Science       Date:  1965-04-16       Impact factor: 47.728

4.  Human gamma globulin fractionation on anion exchange cellulose columns.

Authors:  J L FAHEY; A P HORBETT
Journal:  J Biol Chem       Date:  1959-10       Impact factor: 5.157

5.  Preparation of iodine-131 labelled human growth hormone of high specific activity.

Authors:  W M HUNTER; F C GREENWOOD
Journal:  Nature       Date:  1962-05-05       Impact factor: 49.962

6.  Sandwich solid phase radioimmunoassays for the characterization of human immunoglobulins synthesized in vitro.

Authors:  S E Salmon; B A Smith
Journal:  J Immunol       Date:  1970-03       Impact factor: 5.422

7.  Growth rates and responses to treatment in human myelomatosis.

Authors:  J R Hobbs
Journal:  Br J Haematol       Date:  1969-06       Impact factor: 6.998

Review 8.  Metabolism of immunoglobulins.

Authors:  T A Waldmann; W Strober
Journal:  Prog Allergy       Date:  1969

9.  "Sandwich" solid phase radioimmunoassay for the quantitative deterimination of human immunoglobulins.

Authors:  S E Salmon; G Mackey; H H Fudenberg
Journal:  J Immunol       Date:  1969-07       Impact factor: 5.422

Review 10.  Progress and perspectives in the chemotherapy of acute leukemia.

Authors:  E Frei; E J Freireich
Journal:  Adv Chemother       Date:  1965
View more
  37 in total

1.  Serum free light chains in myeloma patients with an intact M protein by immunofixation: potential roles for response assessment and prognosis during induction therapy with novel agents.

Authors:  Sherry Mori; Brooke S Crawford; Julianna Vf Roddy; Gary Phillips; Pat Elder; Craig C Hofmeister; Yvonne Efebera; Don M Benson
Journal:  Hematol Oncol       Date:  2011-10-26       Impact factor: 5.271

2.  Single-cell exomes in an index case of amp1q21 multiple myeloma reveal more diverse mutanomes than the whole population.

Authors:  Dean Bryant; Will Tapper; Nicola J Weston-Bell; Arnold Bolomsky; Li Song; Shengtao Xu; Andrew R Collins; Niklas Zojer; Surinder Singh Sahota
Journal:  Blood       Date:  2018-05-18       Impact factor: 22.113

Review 3.  Cancer in light of experimental evolution.

Authors:  Kathleen Sprouffske; Lauren M F Merlo; Philip J Gerrish; Carlo C Maley; Paul D Sniegowski
Journal:  Curr Biol       Date:  2012-09-11       Impact factor: 10.834

Review 4.  Cancer Clonal Theory, Immune Escape, and Their Evolving Roles in Cancer Multi-Agent Therapeutics.

Authors:  Jonathan L Messerschmidt; Prianka Bhattacharya; Gerald L Messerschmidt
Journal:  Curr Oncol Rep       Date:  2017-08-12       Impact factor: 5.075

5.  [Paraproteins as the product of clonal immune proliferation--a contribution to the immunology and oncology of monoclonal proteins (author's transl)].

Authors:  O Wetter
Journal:  Klin Wochenschr       Date:  1973-09-15

Review 6.  Immunocytoma o' mice an' men.

Authors:  J R Hobbs
Journal:  Br Med J       Date:  1971-04-10

7.  [The beginning plasmacytoma].

Authors:  H Brücher
Journal:  Blut       Date:  1974-02

8.  Primary bioassay of human myeloma stem cells.

Authors:  A Hamburger; S E Salmon
Journal:  J Clin Invest       Date:  1977-10       Impact factor: 14.808

9.  Ectopic production of the isolated beta subunit of human chorionic gonadotropin.

Authors:  B D Weintraub; S W Rosen
Journal:  J Clin Invest       Date:  1973-12       Impact factor: 14.808

10.  Soluble syndecan-1 at diagnosis and during follow up of multiple myeloma: a single institution study.

Authors:  Ji Myung Kim; Jung Ae Lee; In Sung Cho; Chun Hwa Ihm
Journal:  Korean J Hematol       Date:  2010-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.